Should we stop prescribing pioglitazone?
- PMID: 24528104
- PMCID: PMC4137839
- DOI: 10.1111/bcp.12342
Should we stop prescribing pioglitazone?
Comment on
-
Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.Br J Clin Pharmacol. 2014 Aug;78(2):258-73. doi: 10.1111/bcp.12306. Br J Clin Pharmacol. 2014. PMID: 24325197 Free PMC article.
References
-
- Erdmann E, Song E, Spanheimer R, van Troostenburg de Bruyn AR, Perez A. Observational follow-up of the PROactive study: a 6-year update. Diabetes Obes Metab. 2014;16:63–74. - PubMed
-
- Betteridge DJ, DeFronzo RA, Chilton RJ. PROactive: time for a critical appraisal. Eur Heart J. 2008;29:969–983. - PubMed
-
- Nissen SE, Wolski K. Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med. 2010;170:1191–1201. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
